Ryuichi Nishii Selected Research

multidrug resistance-associated protein 1

1/2022	A single high-dose irradiation changes accumulation of methotrexate and gene expression levels of SLC and ABC transporters in cancer cells.
11/2020	[131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryuichi Nishii Research Topics

Disease

30	Neoplasms (Cancer) 01/2024 - 05/2004
8	Breast Neoplasms (Breast Cancer) 03/2021 - 04/2014
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2008
5	Amyloid Plaque 05/2018 - 10/2010
4	Carcinoma (Carcinomatosis) 03/2021 - 04/2017
4	Melanoma (Melanoma, Malignant) 11/2020 - 06/2015
3	Bacterial Infections (Bacterial Infection) 03/2023 - 02/2022
3	Atherosclerosis 10/2021 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 10/2010
3	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 05/2011
3	Seizures (Absence Seizure) 01/2013 - 01/2010
2	Lung Neoplasms (Lung Cancer) 06/2020 - 05/2008
2	Lymphoma (Lymphomas) 11/2018 - 01/2018
2	Hypoxia (Hypoxemia) 11/2018 - 04/2009
2	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2017
2	Hypothyroidism 01/2018 - 09/2004
2	Experimental Melanoma 01/2018 - 06/2015
2	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2011
2	Glioma (Gliomas) 01/2017 - 04/2009
2	Stroke (Strokes) 08/2012 - 03/2011
2	Infarction (Infarctions) 03/2011 - 12/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2006 - 02/2002
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Neuroinflammatory Diseases 01/2024
1	Communicable Diseases (Infectious Diseases) 03/2023
1	Esophageal Neoplasms (Esophageal Cancer) 11/2022
1	Infections 02/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Colitis 12/2021
1	Radiation Pneumonitis 01/2021
1	Neuroblastoma 11/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2006
11	Amino Acids FDA Link 03/2023 - 05/2004
6	ErbB Receptors (EGF Receptor)IBA 01/2024 - 01/2014
6	Multidrug Resistance-Associated ProteinsIBA 01/2022 - 11/2018
5	Tyrosine Kinase InhibitorsIBA 01/2024 - 04/2017
5	Methionine (L-Methionine)FDA Link 11/2022 - 11/2012
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 05/2009
5	3-Iodobenzylguanidine (Iobenguane)IBA 12/2021 - 02/2002
5	benzofuranIBA 05/2018 - 10/2010
4	AcidsIBA 05/2022 - 05/2011
4	Organic Anion TransportersIBA 01/2022 - 11/2007
4	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2022 - 04/2014
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2021 - 11/2018
4	Adenosine Triphosphate (ATP)IBA 11/2020 - 04/2014
4	Amyloid (Amyloid Fibrils)IBA 11/2018 - 11/2011
3	Amino Acid Transport Systems (Amino Acid Transporter)IBA 03/2023 - 05/2011
3	Peptides (Polypeptides)IBA 01/2022 - 01/2019
3	Probenecid (Benemid)FDA LinkGeneric 03/2021 - 11/2007
3	verlukastIBA 11/2020 - 11/2018
3	2,2-dimethyl-beta-alanineIBA 01/2018 - 10/2016
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 11/2007
3	EnzymesIBA 01/2018 - 03/2009
3	Oxygen (Dioxygen)IBA 09/2015 - 12/2009
3	GABA-A Receptors (GABA(A) Receptor)IBA 01/2012 - 12/2009
2	Alanine (L-Alanine)FDA Link 03/2023 - 01/2017
2	RadiopharmaceuticalsIBA 05/2022 - 01/2018
2	Radioisotopes (Radionuclides)IBA 02/2022 - 06/2017
2	AnionsIBA 01/2022 - 11/2020
2	multidrug resistance-associated protein 1IBA 01/2022 - 11/2020
2	CholesterolIBA 10/2021 - 02/2002
2	CationsIBA 03/2021 - 11/2020
2	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 04/2014
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2018 - 04/2018
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2018 - 06/2015
2	ThymidineIBA 01/2018 - 06/2015
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 05/2011
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2018 - 06/2015
2	Acetates (Acetic Acid Esters)FDA Link 01/2018 - 01/2013
2	Phenylthiourea (Phenylthiocarbamide)IBA 01/2018 - 06/2015
2	Melanins (Melanin)IBA 01/2018 - 06/2015
2	Small Interfering RNA (siRNA)IBA 01/2013 - 05/2011
2	Flumazenil (Romazicon)FDA LinkGeneric 01/2012 - 01/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 11/2006
1	acetamideIBA 01/2024
1	N- benzyl- N- methyl- 2- (7,8- dihydro- 7- (2- fluoroethyl)- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 01/2024
1	olmutinibIBA 01/2024
1	GadoliniumIBA 01/2023
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2023
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2023
1	Human Serum Albumin FDA LinkGeneric 01/2023
1	osimertinibIBA 10/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Dextrans (Dextran)FDA Link 12/2021
1	Cimetidine (Biomet)FDA LinkGeneric 12/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 12/2021
1	Molecular Probes (Molecular Probe)IBA 03/2021
1	Technetium Tc 99m Dimercaptosuccinic AcidIBA 03/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 03/2021
1	Carbon-11IBA 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 02/2021
1	sodium-bile acid cotransporterIBA 11/2020
1	Inosine Monophosphate (IMP)IBA 11/2020

Therapy/Procedure

10	Therapeutics 11/2018 - 02/2002
3	Heavy Ion Radiotherapy 01/2023 - 01/2021
2	Chemoradiotherapy 01/2022 - 01/2018
2	Radiotherapy 01/2022 - 03/2011
2	Thyroidectomy 05/2011 - 09/2004